These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The isoprenoid substrate specificity of isoprenylcysteine carboxylmethyltransferase: development of novel inhibitors. Anderson JL; Henriksen BS; Gibbs RA; Hrycyna CA J Biol Chem; 2005 Aug; 280(33):29454-61. PubMed ID: 15946942 [TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of the integral membrane methyltransferase isoprenylcysteine carboxyl methyltransferase (ICMT) reveals potential substrate binding sites. Diver MM; Long SB J Biol Chem; 2014 Sep; 289(38):26007-26020. PubMed ID: 25059662 [TBL] [Abstract][Full Text] [Related]
7. 9 Structure and function of isoprenylcysteine carboxylmethyltransferase (Icmt): A key enzyme in CaaX processing. Anderson JL; Hrycyna CA Enzymes; 2006; 24():245-72. PubMed ID: 26718043 [TBL] [Abstract][Full Text] [Related]
12. Probing the isoprenylcysteine carboxyl methyltransferase (Icmt) binding pocket: sulfonamide modified farnesyl cysteine (SMFC) analogs as Icmt inhibitors. Majmudar JD; Hahne K; Hrycyna CA; Gibbs RA Bioorg Med Chem Lett; 2011 May; 21(9):2616-20. PubMed ID: 21334890 [TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha stimulation of Rac1 activity. Role of isoprenylcysteine carboxylmethyltransferase. Papaharalambus C; Sajjad W; Syed A; Zhang C; Bergo MO; Alexander RW; Ahmad M J Biol Chem; 2005 May; 280(19):18790-6. PubMed ID: 15647276 [TBL] [Abstract][Full Text] [Related]
14. Amide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferase. Donelson JL; Hodges HB; Macdougall DD; Henriksen BS; Hrycyna CA; Gibbs RA Bioorg Med Chem Lett; 2006 Aug; 16(16):4420-3. PubMed ID: 16777414 [TBL] [Abstract][Full Text] [Related]
15. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation. Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway. Pan Q; Liu R; Banu H; Ma L; Li H Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763 [TBL] [Abstract][Full Text] [Related]
17. Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism. Teh JT; Zhu WL; Ilkayeva OR; Li Y; Gooding J; Casey PJ; Summers SA; Newgard CB; Wang M Oncogene; 2015 Jun; 34(25):3296-304. PubMed ID: 25151967 [TBL] [Abstract][Full Text] [Related]
18. Purification, functional reconstitution, and characterization of the Saccharomyces cerevisiae isoprenylcysteine carboxylmethyltransferase Ste14p. Anderson JL; Frase H; Michaelis S; Hrycyna CA J Biol Chem; 2005 Feb; 280(8):7336-45. PubMed ID: 15611058 [TBL] [Abstract][Full Text] [Related]
19. Isoprenylcysteine carboxyl methyltransferase modulates endothelial monolayer permeability: involvement of RhoA carboxyl methylation. Lu Q; Harrington EO; Hai CM; Newton J; Garber M; Hirase T; Rounds S Circ Res; 2004 Feb; 94(3):306-15. PubMed ID: 14699010 [TBL] [Abstract][Full Text] [Related]
20. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells. Bergo MO; Leung GK; Ambroziak P; Otto JC; Casey PJ; Young SG J Biol Chem; 2000 Jun; 275(23):17605-10. PubMed ID: 10747846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]